Skip to main content

Bank of New York Mellon Corp

Bank

Position in MYGN — Myriad Genetics Inc

CIK 1390777 NEW YORK, NY

Position in MYGN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,505,308
-$2,074,684 QoQ
Shares Held
334,513
-42.5% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 83% Shared 0% None 17%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $5,997,096,545 across 34 Diagnostics & Research names. MYGN ranks #27 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,505,308 334,513
2025-12-31 $3,579,992 582,113
2025-09-30 $4,229,242 584,958
2025-06-30 $3,319,395 625,122
2025-03-31 $5,516,604 621,940
2024-12-31 $8,856,698 646,003
2024-09-30 $17,632,226 643,747
2024-06-30 $17,593,855 719,291
2024-03-31 $14,735,870 691,176
2023-12-31 $13,686,858 715,092
2023-09-30 $11,256,133 701,754
2023-06-30 $17,157,393 740,181
2023-03-31 $17,605,503 757,878
2022-12-31 $11,770,335 811,188
2022-09-30 $16,054,348 841,423
2022-06-30 $14,979,599 824,414
2022-03-31 $23,334,241 925,962
2021-12-31 $25,783,339 934,179
2021-09-30 $29,940,254 927,230
2021-06-30 $27,387,079 895,588
2021-03-31 $27,376,861 899,076
2020-09-30 $12,296,143 942,956
2020-06-30 $10,707,191 944,197
2020-03-31 $12,762,715 891,874